| Symbol | IMDX |
|---|---|
| Name | INSIGHT MOLECULAR DIAGNOSTICS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Address | 2 INTERNATIONAL PLAZA DR.,SUITE 510, NASHVILLE, 37217, United States |
| Telephone | +1 949 409-7600 |
| Fax | — |
| — | |
| Website | https://www.oncocyte.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001642380 |
| Description | Insight Molecular Diagnostics Inc., or iMDx (formerly Oncocyte Corporation), is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information. Additional info from NASDAQ: |
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
Read more(30% Negative) INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX) Reports Q3 2026 Financial Results
Read moreNew Form S-8 - Insight Molecular Diagnostics Inc. <b>Filed:</b> 2026-07-24 <b>AccNo:</b> 0001493152-26-034564 <b>Size:</b> 271 KB
Read moreiMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
Read moreFavorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
Read moreDirector SILVERMAN LOU 🔴 sold 7.7K shares of Insight Molecular Diagnostics Inc. (IMDX) at $5.69 Transaction Date: Jul 01, 2026 | Filing ID: 032235
Read moreDirector Last Andrew J. 🔴 sold 7.7K shares of Insight Molecular Diagnostics Inc. (IMDX) at $5.69 Transaction Date: Jul 01, 2026 | Filing ID: 032233
Read moreDirector Arno Andrew 🔴 sold 12.1K shares of Insight Molecular Diagnostics Inc. (IMDX) at $5.69 Transaction Date: Jul 01, 2026 | Filing ID: 032231
Read moreIMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
Read moreiMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
Read more